In addition, this work provides a collection of four metagene signatures, consisting of coding and non-coding GATA4/6 targets, with elevated diagnostic and prognostic potency for GI cancer based on analysis in a multi-cancer panel. The gene discussed is GATA4; the disease is cancer.